awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48330948-787E2496-BAC4-45A4-A2C2-C8E3C2FD49A9
Q48330948-787E2496-BAC4-45A4-A2C2-C8E3C2FD49A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48330948-787E2496-BAC4-45A4-A2C2-C8E3C2FD49A9
Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening.
P2860
Q48330948-787E2496-BAC4-45A4-A2C2-C8E3C2FD49A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48330948-787E2496-BAC4-45A4-A2C2-C8E3C2FD49A9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8784eef04903d25430741767c0e3716794cd1919
P2860
SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.